Westfield Capital Management
BIVV

Westfield Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Westfield Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-864,275
Closed -$46.6M – 276
2017
Q4 		$46.6M Buy
864,275
+107,066
+14% +$5.86M 0.36% 106
2017
Q3 		$43.2M Buy
757,209
+444,889
+142% +$26.1M 0.33% 109
2017
Q2 		$18.8M Sell
312,320
-116,514
-27% -$6.63M 0.16% 174
2017
Q1 		$23.4M Buy
+428,834
New +$21.1M 0.2% 152

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Westfield Capital Management's BIVV Position: Q1 2018 in Review

Westfield Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 864,275 shares — an estimated $46.6M sold.

Westfield Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $46.6M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Westfield Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Westfield Capital Management sold 864,275 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $46.6M.
  • Westfield Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Westfield Capital Management's Bioverativ Inc. Common Stock position peaked at $46.6M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Westfield Capital Management's 13F filing for Q1 2018, filed 14 May 2018.